- cafead   Nov 09, 2021 at 11:12: AM
via The U.S. government has agreed to pay Merck & Co. about $1 billion for another 1.4 million treatment courses of its COVID-19 pill molnupiravir, nearly doubling its stockpile ahead of potential Food and Drug Administration authorization next month.
article source
article source